MPT: Sildenafil Fails in Valve Disease with Residual PH

ACC Conference Reporter

ESC 2017 | BARCELONA — Sildenafil should not be used as treatment for residual pulmonary hypertension in patients with valvular heart disease as it lead to worse clinical outcomes, according to results from the SIOVAC trial. Read More >>>

Keywords: ESC2017, ESC Congress

< Back to Listings